Tepotinib Improves Prognosis in an Elderly Patient with Poor Performance Status and MET Exon 14 Skipping Mutation-positive Non-small Cell Lung Cancer.
Year: 2022
Type: article
Source: PubMed
Authors: Arihito Tanaka, Fumihiro Kashizaki, Shunsuke Sugimoto, Shigeaki Hattori, Natsumi Yazaki, Syohei Obayashi, Asako Kitahara, Koichiro Asano
Institution: Tokai University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4223895331
